Leptin and HER2 Interaction in Breast Cancer
Author Information
Author(s): Fiorio Elena, Mercanti Anna, Terrasi Marianna, Micciolo Rocco, Remo Andrea, Auriemma Alessandra, Molino Annamaria, Parolin Veronica, Di Stefano Bruno, Bonetti Franco, Giordano Antonio, Cetto Gian Luigi, Surmacz Eva
Primary Institution: Temple University
Hypothesis
Can leptin and HER2 interact in breast cancer cells and tissues?
Conclusion
The coexpression of HER2 and the leptin/ObR system may enhance HER2 activity and reduce sensitivity to anti-HER2 treatments.
Supporting Evidence
- Leptin and ObR were coexpressed in all studied breast cancer cell lines.
- In MCF-7 cells, leptin treatment increased HER2 phosphorylation.
- The presence of leptin was correlated with ObR in 93% of breast cancer cases.
Takeaway
This study found that a hormone called leptin and a protein called HER2 work together in some breast cancer cells, which might make the cancer harder to treat.
Methodology
The study used immunoblotting, immunoprecipitation, and immunohistochemistry to assess the expression and interaction of leptin and HER2 in breast cancer cell lines and tissues.
Limitations
The study had a limited sample size, which may affect the generalizability of the findings.
Participant Demographics
The study included 59 women with breast cancer, of which 31 were HER2-positive and 28 were HER2-negative.
Statistical Information
P-Value
< 0.001
Statistical Significance
p<0.001
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website